The Newcomer Podcast A Very Stable “Coin” GENIUS
May 16, 2025
Eric shares insights from a biotech summit in Park City, highlighting funding cuts and mixed sentiments in the industry. There's optimism around AI tools, while fintech buzzes with hopes for IPOs and stablecoins. However, concerns about currency stability linger due to tariffs. Madeline discusses how stricter immigration policies are impacting startup talent, leaving many uneasy. This dynamic poses challenges for innovation, especially as the industry grapples with political pressures and the need for a diverse workforce.
AI Snips
Chapters
Transcript
Episode notes
Biotech Funding Cuts Worry Scientists
- University funding cuts due to Trump administration policies worry biotech professionals.
- Such reductions in research funding will have damaging long-term impacts on drug discovery and innovation.
Immigration Crackdowns Threaten Biotech Talent
- Immigration policy crackdowns create significant talent risk for biotech and research industries.
- American labs depend heavily on Chinese talent, who face increasing obstacles under current immigration tactics.
AI’s Growing Role in Drug Discovery
- AI is widely embraced in biotech, especially in drug discovery using generative models.
- Despite enthusiasm, no company has fully discovered a drug yet using AI; drug development remains lengthy.